Differential Gene Expression in Diabetic Nephropathy in Individuals With Type 1 Diabetes
Author(s) -
Maria Luiza Caramori,
YoungKi Kim,
Allison B. Goldfine,
Jason H. Moore,
Stephen S. Rich,
Josyf C. Mychaleckyj,
David T. Kirkpatrick,
Helen Nickerson,
Andrzej S. Królewski,
Michael Mauer
Publication year - 2015
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2014-4465
Subject(s) - diabetic nephropathy , epigenetics , diabetes mellitus , endocrinology , medicine , kegg , nephropathy , genome wide association study , type 2 diabetes , type 1 diabetes , transcriptome , biology , end stage renal disease , gene expression , gene , bioinformatics , genetics , disease , single nucleotide polymorphism , genotype
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) in the United States.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom